However, this earlier study did not comprehensively examine COVID-19 associated CNS medication trends among a more cognitively vulnerable AL cohort, including the use of anti-dementia drugs (cholinesterase inhibitors, memantine), or explore the relevance of residents’ age and sex and AL home characteristics (including resident COVID-19 cases), in adjusted models [22]. The gene discussed is BCHE; the disease is COVID-19.